ISIntuitive Surgical statistics
$443.59+0.84%Close 13 Nov 2026 · Market value $152.6B
Valuation and share-price figures are struck on the latest close (13 Nov 2026); the others are read from the company's reports. A figure that cannot be worked out, such as a P/E after a loss, is left out.
Valuation
Intuitive Surgical is valued at $152.6B on its latest close. Its price is 51.6 times its earnings.
| Market value | $152.6B |
|---|
| Enterprise value | $149.8B |
|---|
| Price / earnings | 51.61 |
|---|
| Price / sales | 13.18 |
|---|
| Price / book | 9.55 |
|---|
| EV / EBITDA | 36.35 |
|---|
| EV / sales | 12.94 |
|---|
| Price / free cash flow | 42.42 |
|---|
| Price / free cash flow, own 5-year average | 121.37 |
|---|
| EV / EBIT | 45.24 |
|---|
| EV / free cash flow | 41.29 |
|---|
| Free cash flow yield | 2.4% |
|---|
Share price
| Latest close | $443.59 |
|---|
| Day's change | +0.8% |
|---|
| 52-week high | $603.88 |
|---|
| 52-week low | $328.57 |
|---|
| From 52-week high | −26.5% |
|---|
| Return · 1 month | +4.0% |
|---|
| Return · 3 months | +18.5% |
|---|
| Return · year to date | −21.7% |
|---|
| Return · 1 year | −22.5% |
|---|
| Beta · 1 year against the S&P 500 | 0.90 |
|---|
| 50-day average | $417.59 |
|---|
| 200-day average | $429.38 |
|---|
| RSI 14 | 52.1 |
|---|
| Average volume · 20 sessions | 2.7M |
|---|
Margins and returns
For fiscal 2025, as filed.
| Gross margin | 66.0% |
|---|
| Operating margin | 29.3% |
|---|
| Net margin | 28.4% |
|---|
| Free cash flow margin | 24.7% |
|---|
| Return on equity | 16.7% |
|---|
| Return on assets | 13.1% |
|---|
| Return on invested capital | 19.3% |
|---|
| Return on invested capital, 5-year average | 19.3% |
|---|
| Return on capital employed | 16.6% |
|---|
| Stock-based compensation / revenue | 7.8% |
|---|
Financial position
At the end of fiscal 2025.
| Cash and equivalents | $3.37B |
|---|
| Current ratio | 4.87 |
|---|
| Quick ratio | 2.28 |
|---|
Growth
| Revenue, latest quarter on a year | +21.7% |
|---|
| Revenue, twelve months on a year | +20.5% |
|---|
| EPS, latest quarter on a year | −23.6% |
|---|
| EPS, twelve months on a year | +9.6% |
|---|
| Revenue, 5-year compound | +18.2% |
|---|
| Revenue, 10-year compound | +15.5% |
|---|
| Net income, 5-year compound | +21.9% |
|---|
| Free cash flow, 5-year compound | +16.9% |
|---|
| EPS, 5-year compound | +21.8% |
|---|
Shares and dividends
For fiscal 2025, as filed.
| Diluted shares | 363M |
|---|
| Shares outstanding, 5-year compound | +0.1% |
|---|
| Net share repurchases | $2.07B |
|---|
Taxes
For fiscal 2025, as filed.
| Income tax expense | $434.8M |
|---|
| Effective tax rate | 13.1% |
|---|
ISRG in the terminal
Valuation against the company's own history, a cash-flow valuation, peers, charts and alerts.